Our Financials & Outlook
DEAR SHAREHOLDERS & INVESTORS
We look forward to all that’s to come in 2021, as we continue building on our strengths to reimagine the future.
Our Key Figures 2020 -Unaudited
2020 financial results reflect the downturn in the travel industry and the great progress made across our R&D pipeline.
Shareholder structure (January 2021)
Our capital strategy
Our capital strategy is a combination of non-dilutive funding sources and equity capital to finance the development of the Company’s vaccine candidates.
2021 Outlook
In 2021, Valneva expects to achieve major R&D milestones while increasing R&D investments in its three late-stage product candidates.
